Abstract
Cardiac myxomas are rare tumors with a heterogeneous cell population including properly neoplastic (lepidic), endothelial and smooth muscle cells. The assessment of neoplastic (lepidic) cell differentiation pattern is rather difficult using conventional light microscopy immunohistochemistry and/or whole tissue extracts for mRNA analyses. In a preliminary study, we investigated 20 formalin-fixed and paraffin-embedded cardiac myxomas by means of conventional immunohistochemistry; in 10/20 cases, cell differentiation was also analyzed by real-time RT-PCR after laser capture microdissection of the neoplastic cells, whereas calretinin and endothelial antigen CD31 immunoreactivity was localized in 4/10 cases by double immunofluorescence confocal microscopy. Gene expression analyses of α-smooth muscle actin, endothelial CD31 antigen, alpha-cardiac actin, matrix metalloprotease-2 (MMP2) and tissue inhibitor of matrix metalloprotease-1 (TIMP1) was performed on cDNA obtained from either microdissected neoplastic cells or whole tumor sections. We found very little or absent CD31 and α-Smooth Muscle Actin expression in the microdissected cells as compared to the whole tumors, whereas TIMP1 and MMP2 genes were highly expressed in both ones, greater levels being found in patients with embolic phenomena. α-Cardiac Actin was not detected. Confocal microscopy disclosed two different signals corresponding to calretinin-positive myxoma cells and to endothelial CD31-positive cells, respectively. In conclusion, the neoplastic (lepidic) cells showed a distinct gene expression pattern and no consistent overlapping with endothelial and smooth muscle cells or cardiac myocytes; the expression of TIMP1 and MMP2 might be related to clinical presentation; larger series studies using also systematic transcriptome analysis might be useful to confirm the present results.
Similar content being viewed by others
References
Pucci A, Gagliardotto P, Zanini C, Pansini S, Di Summa M, Mollo F (2000) Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J 140:134–138
Pucci A, Bartoloni G, Tessitore E, Carney JA, Papotti M (2003) Cytokeratin profile and neuroendocrine cells in the glandular component of cardiac myxoma. Virchows Arch 443:618–624
Pucci A, Bartoloni G (2013) Cardiac myxoma. In: Basso C, Valente M, Thiene G (eds) Cardiac tumor pathology. Springer, New York, pp 31–44
Amano J, Kono T, Wada Y, Zhang T, Koine N, Fujimori M, Ito K (2003) Cardiac myxomas: its origin and tumor characteristics. Ann Thorac Cardiovasc Surg 9:215–221
Carney JA (1985) Differences between non-familial and familial cardiac myxoma. Am J Surg Pathol 9:53–55
Stratakis CA, Kirschner LS, Carney JA (2001) Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041–4046
Reynen K (1995) Cardiac myxomas. N Engl J Med 333:1610–1617
Lie TJ (1989) The identity and histogenesis of cardiac myxomas. A controversy put to rest. Arch Pathol Lab Med 113:724–726
Bartoloni G, Pucci A, Giorlandino A, Berretta M, Mignosa C, Italia F, Carbone A, Canzonieri A (2013) Incidental Epstein-Barr virus associated atypical lymphoid proliferation arising in a left atrial myxoma: a case of long survival without any postsurgical treatment and review of the literature. Cardiovasc Pathol 22:e5–10
Tazelaar HD, Locke TJ, McGregor CG (1992) Pathology of surgically excised primary cardiac tumors. Mayo Clin Proc 67:957–965
Burke AP, Veinot JP, Loire R, Virmani R, Tazelaar H, Kamiya H, Araoz PA, Watanabe G (2003) Tumors of the heart. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) Pathology and genetics of tumors of the lung, pleura, thymus and heart. IARC Press, Lyon, pp 249–288
Burke A, Jeudy JJ, Virmani R (2008) Cardiac tumors: an update. Heart 94:117–123
Kodama H, Hirotani T, Suzuki Y, Ogawa S, Yamazaki K (2002) Cardiomyogenic differentiation in cardiac myxoma expressing lineage-specific transcription factors. Am J Pathol 161:381–389
Orlandi A, Ciucci A, Ferlosio A, Genta R, Spagnoli LG, Gabbiani G (2006) Cardiac myxoma cells exhibit embryonic endocardial stem cell features. J Pathol 209:231–239
Terracciano LM, Mhawech P, Suess K, D’Armiento M, Lehmann FS, Jundt G, Moch H, Sauter G, Mihatsch MJ (2000) Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations. Am J Clin Pathol 114:754–759
Sakamoto H, Sakamaki T, Sumino H, Sawada Y, Sato H, Sato M, Fujita K, Kanda T, Tamura J, Kurabayashi M (2004) Production of endothelin-1 and big endothelin-1 by human cardiac myxoma cells—implications of the origin of myxomas. Circ J 68:1230–1232
Skamrov AV, Nechaenko MA, Goryunova LE, Feoktistova ES, Khaspekov GL, Kovalevsky DA, Vinnitsky LI, Sheremeteva GF, Beabealashvilli RSh (2004) Gene expression analysis to identify mRNA markers of cardiac myxoma. J Mol Cell Cardiol 37:717–733
Zhang T, Koide N, Wada Y, Tsukioka K, Takayama K, Kono T, Kitahara H, Amano J (2003) Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma. Circ J 67:54–60
Datta S, Malhotra L, Dickerson R, Chaffee S, Sen CK, Roy S (2015) Laser capture microdissection: big data from small samples. Histol Histopatol 30:1255–1269
Keays KM, Owens GP, Ritchie AM, Gilden DH, Burgoon MP (2005) Laser capture microdissection and single-cell RT-PCR without RNA purification. J Immunol Methods 302:90–98
Gošev I, Paić F, Durić Z, Gošev M, Ivčević S, Jakuš FB, Biočina B (2013) Cardiac myxoma the great imitators: comprehensive histopathological and molecular approach. Int J Cardiol 164:7–20
Orlandi A, Ciucci A, Ferlosio A, Pellegrino A, Chiariello L, Spagnoli LG (2005) Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas. Am J Pathol 166:1619–1628
Liu C, Jung S, Orlandi A, Yeh T, Lin Y, Shiu T, Wu H, Chu J, Lin P, Chu P (2010) The fas-mediated apoptotic pathway in cardiac myxoma. Int J Surg Pathol 18:493–498
Pusztaszeri MP, Seelentag W, Bosman FT (2006) Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 5:385–395
Jensen EC (2014) Technical review: colocalization of antibodies using confocal microscopy. Anat Rec (Hoboken) 297:183–187
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Pucci, A., Mattioli, C., Matteucci, M. et al. Cell differentiation in cardiac myxomas: confocal microscopy and gene expression analysis after laser capture microdissection. Heart Vessels 33, 1403–1410 (2018). https://doi.org/10.1007/s00380-018-1189-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-018-1189-2